Home Proteases -Metabolism Neprilysin

Neprilysin

Choose Selective Neprilysin Inhibitors

Neprilysin Products

  • All (3)
  • Neprilysin Inhibitors (3)
  • New Neprilysin Products
Catalog No. Product Name Information Product Use Citations Product Validations
S3388 Sacubitrilat Sacubitrilat (Sac, LBQ-657) is an active inhibitor of neprilysin (NEP).
S4426 Sacubitril hemicalcium salt Sacubitril (AHU-377) hemicalcium salt, a component of the heart failure medicine LCZ696, is a potent inhibitor of neprilysin (neutral endopeptidase, NEP).
S7678 Sacubitril/valsartan (LCZ696) Sacubitril/valsartan (LCZ696, Sacubitril, Valsartan), consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure. Phase 3.
Arch Toxicol, 2022, 96(4):1065-1074
Cardiovasc Res, 2021, 117(5):1391-1401
Neurotox Res, 2021, 10.1007/s12640-021-00414-1
S3388 Sacubitrilat Sacubitrilat (Sac, LBQ-657) is an active inhibitor of neprilysin (NEP).
S4426 Sacubitril hemicalcium salt Sacubitril (AHU-377) hemicalcium salt, a component of the heart failure medicine LCZ696, is a potent inhibitor of neprilysin (neutral endopeptidase, NEP).
S7678 Sacubitril/valsartan (LCZ696) Sacubitril/valsartan (LCZ696, Sacubitril, Valsartan), consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure. Phase 3.
Arch Toxicol, 2022, 96(4):1065-1074
Cardiovasc Res, 2021, 117(5):1391-1401
Neurotox Res, 2021, 10.1007/s12640-021-00414-1
Tags: Neprilysin inhibitor|Neprilysin agonist|Neprilysin activator|Neprilysin inducer|Neprilysin antagonist|Neprilysin signaling pathway|Neprilysin assay kit